Mesoblast's Strong Cash Position Enables Execution of Late-Stage Clinical Trials NEW YORK and MELBOURNE, Australia, Aug. 29, 2013 (GLOBE NEWSWIRE) -- Regenerative medicine company, Mesoblast Limited (ASX:MSB) (OTC ADR:MBLTY), today provided its full year financial results. The...

Houston Colorectal Surgeon Provides Incisionless Technique to Remove Rectal Tumors HOUSTON, TX--(Marketwired - May 2, 2013) - Houston colorectal surgeon Dr. Eric Haas and his team at Colorectal Surgical Associates are now offering patients an incisionless and minimally-invasive...

Antisense Therapeutics to Present at Rodman & Renshaw 11th Annual Healthcare Conference MELBOURNE, AUSTRALIA--(Marketwire - August 31, 2009) - Antisense Therapeutics Limited (PINKSHEETS: ATHJY) (ASX: ANP) today announced that the Company is scheduled to present at the Rodman &...